ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Session date: 
Friday, September 27, 2019 - 8:00am to 9:00am
Medical College of WI
8701 Watertown Plank Rd
Health Research Center - Bolger Auditorium #H1400
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Target audience: 

Allied Health Care Professionals

Learning objectives: 
  1. Briefly review currently available acute pharmacotherapies
  2. Discuss small molecule calcitonin gene related peptide inhibitors (“gepants”)
  3. Discuss novel selective serotonin 5-HT1F receptor agonist (lasmiditan)



Faculty & credentials: 

Derrick Shumate, DO
Assistant Professor
Department of Neurology
Medical College of Wisconsin


All persons in control of content have NO relevant financial relationships to disclose.

CME Coordinator Contact Information

Laura Kurth
Phone number: 
+1 (414) 955-0650